Optiscan Imaging Ltd. is a medical technology company specializing in the development, manufacturing, and commercialization of advanced confocal endomicroscopic imaging systems. The company's core products enable real-time, three-dimensional, in vivo imaging at the single-cell level, allowing clinicians and researchers to visualize live tissues without the need for traditional biopsies or slides. These technologies are applied in a variety of settings, including digital pathology, precision surgery, and pre-clinical research, with the aim of improving disease detection, surgical outcomes, and reducing healthcare costs. Notably, Optiscan Imaging collaborates with leading healthcare institutions, such as the Mayo Clinic, to further develop its digital imaging solutions for applications like robotic surgery. Its portfolio includes devices tailored for medical practitioners, researchers, and even veterinary medicine, reflecting a versatile and innovative approach to microscopic imaging across sectors. Through its proprietary, miniaturized digital microscopes, Optiscan Imaging Ltd. plays a significant role in advancing the fields of early disease diagnosis, cancer management, and precision healthcare, helping to transform standards of care globally.